|
EP2046350A2
|
|
Composition and method for delivery of bmp-2 amplifier/co-activator for enhancement of osteogenesis
|
|
US7820172B1
|
|
Laminin-derived multi-domain peptides
|
|
WO2006093814A2
|
|
Fgf growth factor analogs
|
|
US2009111743A1
|
|
Cysteine-branched heparin-binding growth factor analogs
|
|
US2006205652A1
|
|
Formulations and methods for delivery of growth factor analogs
|
|
US2008227696A1
|
|
Single branch heparin-binding growth factor analogs
|
|
US2006024347A1
|
|
Bioactive peptide coatings
|
|
US2005222394A1
|
|
Dual chain synthetic heparin-binding growth factor analogs
|
|
WO2005082005A2
|
|
Positive modulator of bone morphogenic protein-2
|
|
US7528105B1
|
|
Heterodimeric chain synthetic heparin-binding growth factor analogs
|
|
US7414028B1
|
|
Growth factor analogs
|
|
US7468210B1
|
|
Cross-linked heparin coatings and methods
|
|
US2004151764A1
|
|
Bioactive medical films
|
|
EP1539801A2
|
|
Synthetic heparin-binding growth factor analogs
|
|
US7700563B2
|
|
Synthetic heparin-binding factor analogs
|
|
US6765069B2
|
|
Plasma cross-linked hydrophilic coating
|
|
US6596699B2
|
|
Nucleic acid coating compositions and methods
|
|
US6921811B2
|
|
Bioactive coating composition and methods
|
|
WO0203890A1
|
|
Drug diffusion coatings, applications and methods
|
|
US6575888B2
|
|
Bioabsorbable brachytherapy device
|
